DETP: One of the Footprints Organophosphate Pesticides Leave Behind

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This urine test measures diethylthiophosphate (DETP), a biomarker of exposure to organophosphate pesticides, helping you identify and reduce recent pesticide exposure. Lowering exposure may reduce risks linked to nervous system effects and potential cognitive/developmental impacts.

Read more →

Understand what your environmental toxins results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

DETP: One of the footprints organophosphates leave behind

Diethylthiophosphate (DETP) is a common breakdown product of several diethyl organophosphate insecticides used in agriculture and, less often today, in homes and gardens. Think of DETP as one of the “footprints” organophosphates leave behind after your body processes them. You can encounter organophosphates through produce with residues, indoor or outdoor pest treatments, drift from nearby applications, and contaminated dust. Labs typically measure DETP in urine, often correcting for creatinine to account for dilution. Because organophosphates are metabolized and cleared relatively quickly, urinary DETP reflects recent exposure over the past few days rather than long-term body burden.

Why it matters: the parent organophosphate compounds can inhibit acetylcholinesterase, an enzyme critical for nerve signaling. DETP itself is not the toxic agent, but it signals that exposure to one or more diethyl organophosphates occurred. After absorption, organophosphates are transformed in the liver, with enzymes like cytochrome P450s and paraoxonase modulating activation and detoxification, then excreted as dialkyl phosphate metabolites such as DETP. These pesticides do not bioaccumulate like lead or PCBs; instead, exposure is intermittent and tied to recent contact. Still, research has linked higher prenatal organophosphate metabolite levels with differences in child neurodevelopment, particularly attention and learning outcomes, though more research is needed and urinary metabolites have important limitations.

Why DETP earns a place on a panel

Testing bridges the gap between the products and environments you interact with and the biology happening inside you. A DETP result helps distinguish incidental contact—like a week of salad-heavy meals during peak spraying season—from sustained or higher-intensity exposure more typical of certain jobs, home renovations, or frequent pest treatments. That distinction can clarify whether unexplained symptoms in a high-exposure context (for example, headaches after a recent application) align with recent organophosphate contact, or whether the pattern looks more like background dietary exposure. It is especially informative during pregnancy or fertility planning, in households with young children, and for people working where pesticides are mixed, applied, or handled.

Big picture, DETP is one lens on total environmental risk. No single result tells the whole story. Patterns across multiple organophosphate metabolites, alongside other environmental markers, symptoms, and general health data, give a more reliable signal over time. In higher-exposure settings, clinicians may consider pairing metabolite testing with red blood cell cholinesterase for a more complete assessment. Seasonal changes, recent diet, and timing of sample collection all matter, so trends and context usually guide smarter decisions than any one-off value.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Who tends to find DETP testing most useful

People who live or work near agricultural applications, perform pest control, or handle treated materials often want an objective read on recent exposure. So do families preparing for pregnancy or with infants and toddlers, where minimizing neurotoxicants is a common goal. Health-curious individuals who track their environment the way others track steps or sleep may also test to understand how changes in products, ventilation, or routines show up biologically. National biomonitoring programs have found widespread, low-level detection of organophosphate metabolites in the general population, which is informative context rather than a cause for alarm.

Reading a DETP result

Most labs report urinary DETP against population-based reference ranges, sometimes with creatinine correction to account for urine concentration. For environmental toxins, values closer to the low end are generally preferable when feasible. Interpretation improves when you know what happened in the prior 48–72 hours—foods eaten, spaces treated for pests, or tasks performed at work—and when you repeat testing to see whether a value is a one-time spike or a repeating pattern.

Relatively lower values typically suggest limited recent exposure, which lowers the likelihood of short-term stress on systems that process these compounds, including the liver and the enzymes that clear organophosphates. In pregnancy and early childhood, lower exposures are generally favored because the developing nervous system is more sensitive to environmental inputs, even when effects are small at the individual level.

Relatively higher values can indicate recent or ongoing exposure. That may place added demand on detoxification pathways and, depending on context, could align with neurologic symptoms if exposures are substantial. Because DETP is a non-specific metabolite—it can come from multiple diethyl organophosphates and sometimes from preformed breakdown products present on foods—it cannot identify the exact pesticide or the precise source. Hydration status can also shift a single measurement, which is why creatinine-corrected reporting and repeat testing are useful for clarity.

Here’s how clinicians think through a DETP value. First, they anchor it in time: What exposures in the prior few days could plausibly explain it? Second, they look horizontally across related metabolites—diethyl and dimethyl species—to see a pattern or rule out a one-off. Third, they consider health status and life stage, since pregnancy and early childhood generally warrant a more conservative posture. In higher-exposure occupations, pairing symptom review with cholinesterase testing can help evaluate physiologic impact.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What can shift a DETP reading

This is a simple urine test. Because organophosphates are cleared quickly, timing matters: a sample captures recent exposure rather than cumulative burden. Labs often use mass spectrometry to quantify DETP at very low concentrations and may normalize results to creatinine to account for dilution. Results are typically compared with population data so you can see where you fall relative to others of similar age or region.

Important limitations to keep in mind:

  • Non-specificity: DETP reflects exposure to a class of diethyl organophosphates, not a single pesticide.
  • Preformed metabolites: Some dialkyl phosphates exist on foods as degradates; detecting DETP may overestimate exposure to the active parent compounds.
  • Timing and variability: Day-to-day swings are common, driven by recent meals, applications, and hydration; a single value is only a snapshot.
  • Assay differences: Methods and reference ranges can vary by lab, which can shift absolute numbers while preserving trends.

What to interpret DETP alongside

The most actionable picture emerges when your DETP result is considered alongside other dialkyl phosphate metabolites, general health markers, and your lived context. Over weeks to months, that combination separates short blips from persistent exposure patterns and supports safer, more targeted choices in partnership with your clinician.

What a DETP result can and can't tell you

As with any environmental metric, trends beat snapshots. If your DETP level is higher than expected, the most informative next step is usually to understand the likely source and watch what happens on repeat testing after real-world changes. Over time, that approach moves you from guesswork to grounded insight, keeping the conversation focused on evidence and your specific context.

Frequently Asked Questions

References

  1. Costa LG (2006). Current issues in organophosphate toxicology. *Clinica Chimica Acta*, *366*(1-2), 1-13. https://doi.org/10.1016/j.cca.2005.10.008
  2. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, Trujillo C, Johnson C, Bradman A, Barr DB, Eskenazi B (2011). Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. *Environmental Health Perspectives*, *119*(8), 1189-1195. https://doi.org/10.1289/ehp.1003185
  3. Barr DB, Wong LY, Bravo R, Weerasekera G, Odetokun M, Restrepo P, Kim DG, Fernandez C, Whitehead RD, Perez J, Gallegos M, Williams BL, Needham LL (2011). Urinary concentrations of dialkylphosphate metabolites of organophosphorus pesticides: National Health and Nutrition Examination Survey 1999-2004. *International Journal of Environmental Research and Public Health*, *8*(8), 3063-3098. https://doi.org/10.3390/ijerph8083063
  4. Chen L, Zhao T, Pan C, Ross JH, Krieger RI (2012). Preformed biomarkers including dialkylphosphates (DAPs) in produce may confound biomonitoring in pesticide exposure and risk assessment. *Journal of Agricultural and Food Chemistry*, *60*(36), 9342-9351. https://doi.org/10.1021/jf303116p
  5. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. *Environmental Health Perspectives*, *113*(2), 192-200. https://doi.org/10.1289/ehp.7337

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey